• Explore /
  • Poster
  • / Efficacy and tolerability of sorafenib in unresectable/advanced hepatocellular carcinoma patients: Real-life experience in a Hong Kong tertiary liver cancer institute.

Efficacy and tolerability of sorafenib in unresectable/advanced hepatocellular carcinoma patients: Real-life experience in a Hong Kong tertiary liver cancer institute.

Abstract Poster

Authors

null

Thomas Cheung Yau

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong

Thomas Cheung Yau , Vikki Tang , Roland Ching-Yu Leung , Gin Wai Kwok , Joanne Wing-Yan Chiu , Tan To Cheung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 382)

DOI

10.1200/JCO.2019.37.4_suppl.382

Abstract #

382

Poster Bd #

L2

Abstract Disclosures

Similar Posters

First Author: Ari David Baron

First Author: Jinpeng Li

First Author: Philippe Merle

First Author: Mathias Earl Palmer